Long-term efficacy and safety of solifenacin in pediatric patients aged 6 months to 18 years with neurogenic detrusor overactivity: results from two phase 3 prospective open-label studies期刊界 All Journals 搜尽天下杂志传播学术成果专业期刊搜索期刊信息化学术搜索

Long-term efficacy and safety of solifenacin in pediatric patients aged 6 months to 18 years with neurogenic detrusor overactivity: results from two phase 3 prospective open-label studies

Affiliation:	1. Yale/New Haven Hospital Section of Pediatric Urology, New Haven, CT, USA;2. Department of Pediatric Urology, Ghent University Hospital, Ghent, Belgium;3. Department of Pediatric Urology of the Children''s Memorial Health Institute, Warsaw, Poland;4. Section of Pediatric Nephrology, Philippine Children''s Medical Centre, Manila, Philippines;5. Aston Optometry School, Aston University, Birmingham, UK;6. Astellas Pharma Europe B.V., Leiden, the Netherlands;7. Department of Pediatric Nephrology, Ghent University Hospital, Ghent, Belgium

Abstract:

Keywords:	Children Adolescents Neurogenic urinary bladder Solifenacin
本文献已被 ScienceDirect 等数据库收录！